Over the years, we have built strong relationships with many different companies across the drug development and contract manufacturing industry. From raw material suppliers to specialist analytical service providers to distribution companies, our supply and partner network help keep us moving and deliver client projects on time and on budget.
Two collaborations we are particularly proud of, Juniper Pharma Services and Reach Separations, have allowed us to deliver more rounded chemistry services to our pharmaceutical clients.
In 2012, we formed a strategic alliance with our friends down at Juniper Pharma Services in Nottingham. The partnership was devised to enable the two contract research and manufacturing organisations to deliver end-to-end services from initial drug discovery through to early and late phase manufacturing.
Complementing our expertise in custom synthesis, chemical process development, solid state chemistry and manufacturing, Juniper Pharma Services specialises in advanced characterisation of pharmaceutical and biological materials, formulation & analytical development and clinical trial manufacturing up to and including Phase II.
In just six months, we completed our first API manufacturing and formulation collaborative project, helping a pharmaceutical client, faced with a very tight deadline, to successfully fill two patent applications.
We also have close ties with purification specialist Reach Separations. Based at BioCity in Nottingham, this alliance allows us to deliver more specialist purification and separation services to help our early stage development and medicinal chemistry services.
As part of the collaboration, we provide custom separation for companies in drug discovery. This includes chiral, reverse phase and normal phase chromatography using supercritical fluid chromatography (SFC) and high performance liquid chromatography (HPLC).
Reach Separations’ technical group is led by purification specialist Phil Abbott (Technical Director) who has worked in the pharmaceutical industry for almost 20 years, including several years at AstraZeneca as a separation science group leader.
If you have a project in mind or would like to discuss how our collaborations could help your compound, then get in touch today.